BioSpace News Archive

Goldman Pharmaceutical Group announces the creation of the only FDA registered over-the-counter pet medicines available online and without a prescription, Pet OTC™. Treating animals suffering from motion sickness, digestive issues and emotional distress.

sBLA expected to be filed in early 2022 Seven-day multidose vial and room temperature stability allow for the potential use of tesamorelin with a multidose pen injector

Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the 510k submission of the X-Tack; Endoscopic HeliX Tacking System to the U.S. Food and Drug Administration seeking clearance for the new, through-the-scope, suture-based device designed specifically for closing defects in the lower gastrointestinal tract with additional application

CIRION BioPharma Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced today that the company is now offering new testing services for the screening and clinical diagnosis of COVID–19 and expands its existing laboratory facilities by more than 7,500 sq.ft. (700 sq.m.), bri

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced the completion of patient enrollment in its NORSE 2 clinical trial for ONS-5010 / LYTENAVA™ (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for use in retinal indications.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has begun screening patients for suitability for enrolment in its Phase 2 idiopathic pulmonary fibrosis (IPF) and chronic cough clinical study of its re-purposed drug NP-120 (Ifenprodil).

AbbVie (NYSE: ABBV) will announce its second-quarter 2020 financial results on Friday, July 31, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time . It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com . An archived edition of

International medical imaging IT and cybersecurity company Sectra will install its enterprise imaging solution in many of CHRISTUS Health’s U.S. locations.

Pear Therapeutics, Inc. (“Pear” or the “Company”) today announced that it closed a credit facility for up to $50 million from Perceptive Advisors (“Perceptive”), a leading life sciences investment firm. In connection with the financing, Pear issued warrants to Perceptive, and Sam Chawla of Perceptive received board observer rig

LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping doctors protect patients by testing them for COVID-19 before surgeries and other important treatments.